Tag results:
glioblastoma
Cancer Stem Cell News
Cilium Induction Triggers Differentiation of Glioma Stem Cells
[Cell Reports] Investigators showed that patient-derived glioma-stem cells recruited elevated levels of proteins that ensure the temporal cilium disassembly, leading to suppressed ciliogenesis.
Cancer Stem Cell News
Characterization of Glioblastoma Cancer Stem Cells Sorted by Sedimentation Field-Flow Fractionation Using an Ultrahigh-Frequency Range Dielectrophoresis Biosensor
[Analytical Chemistry] The authors demonstrated the capability of using an ultrahigh-frequency range dielectrophoresis fluidic biosensor as a detector. This implied an important methodological adaptation of sedimentation field-flow fractionation cell sorting by the use of a new compatible carrier liquid DEP buffer.
Cancer Stem Cell News
Downregulated CLIP3 Induces Radioresistance by Enhancing Stemness and Glycolytic Flux in Glioblastoma
[Journal of Experimental & Clinical Cancer Research] Patient-derived glioma stem-like cells, glioblastoma (GBM) cell lines, intracranial GBM xenografts, and GBM sections were used to measure mRNA and protein expression and determine the related molecular mechanisms by qRT-PCR, immunoblot, immunoprecipitation, immunofluorescence, OCR, ECAR, live-cell imaging, and immunohistochemistry.
Neural Cell News
Cilium Induction Triggers Differentiation of Glioma Stem Cells
[Cell Reports] Scientists showed that patient-derived glioma stem cells recruited elevated levels of proteins that ensured the temporal cilium disassembly, leading to suppressed ciliogenesis.
Prostate Cell News
Discovery of Novel Acetamide-Based Heme Oxygenase-1 Inhibitors with Potent In Vitro Antiproliferative Activity
[Journal of Medicinal Chemistry] Heme oxygenase-1 (HO-1) promotes heme catabolism exercising cytoprotective roles in normal and cancer cells. Scientists reported the design, synthesis, molecular modeling, and biological evaluation of novel HO-1 inhibitors.
Cancer Stem Cell News
Transcriptional Control of Brain Tumor Stem Cells by a Carbohydrate Binding Protein
[Cell Reports] The authors reported that the LGALS1 gene, encoding the carbohydrate binding protein, galectin1, is a key regulator of brain tumor stem cells and glioblastoma resistance to therapy.